| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DRNA | Common Stock | Options Exercise | $272,700 | +30,000 | +188% | $9.09 | 46,000 | 06 Jul 2021 | Direct | |
| transaction | DRNA | Common Stock | Sale | $1,172,700 | -30,000 | -65% | $39.09 | 16,000 | 06 Jul 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DRNA | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -30,000 | -47% | $0.000000 | 33,999 | 06 Jul 2021 | Common Stock | 30,000 | $9.09 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The Reporting Person sold an aggregate of 30,000 shares of Common Stock on July 6, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 3.78% of 794,128 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2020. |
| F3 | The option vests in 48 monthly installments over the four-year period with a vesting start date of January 8, 2016, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date. |